AsianScientist (Apr. 8, 2021) – As Singapore’s Research, Innovation and Enterprise (RIE) 2025 plan kicks into excessive gear, precision medicine is ready to play a much bigger half in defending the well being of all Singaporeans. In keeping with this initative, Precision Health Research, Singapore (PRECISE) has been established to drive the Part II of the nation’s Nationwide Precision Medication (NPM) technique.
In comparison with the ‘one-size-fits-all’ method nonetheless generally seen in healthcare, precision medication takes into consideration genomic, life-style and environmental elements for a extra complete understanding of well being and illness. Not solely can precision medication open the doorways to extra correct diagnoses, however it could possibly assist clinicians prescribe the appropriate drug to the appropriate sufferers, inform the event of latest medication and assist Singapore deal with its distinctive healthcare challenges in a sustainable means.
In 2017, Singapore launched its ten-year NPM technique to determine the required frameworks and infrastructure to comprehend precision medication on a nationwide scale. Because the central entity coordinating the whole-of-government effort for the NPM technique in Part II, PRECISE goals to broaden present analysis efforts, set up nationwide scientific workflows in addition to create new financial alternatives for Singapore’s healthcare and biomedical know-how business.
Since its inception, the technique has already seen early success, together with the world’s largest genetic databank for multi-ethnic Asian populations, also referred to as the SG10K_Health mission.
On this second section, one purpose of the NPM technique is to scale up SG10K_Health to investigate the genetic make-up of 100,000 wholesome Singaporeans and as much as 50,000 sufferers with particular ailments. Known as SG100K, the mission is a collaboration between the Company for Science, Know-how and Analysis (A*STAR), Nanyang Technological College’s Lee Kong Chian Faculty of Medication, Nationwide Healthcare Group, Nationwide College Well being System, Nationwide College of Singapore and the SingHealth Duke-NUS Educational Medical Centre.
“With insights into these disease-causing elements, researchers and docs can develop new approaches that won’t solely profit sufferers within the brief time period however for many years to come back,” stated Professor John Chambers, Chief Scientific Officer of PRECISE.
In the meantime, precision medication can even be piloted within the clinic, in hopes of enhancing affected person outcomes. Lastly, NPM Part II will proceed to companion the Nationwide Analysis Basis Singapore (NRF), A*STAR, the Financial Growth Board and the Heath Promotion Board to draw abroad firms whereas yielding new alternatives for homegrown enterprises.
“PRECISE shall be seeking to develop significant public-private partnership fashions to facilitate development and drive innovation throughout the healthcare and biotechnology business—creating higher-value jobs, nurturing the subsequent technology of scientists and clinicians and strengthening Singapore’s standing because the area’s main medical hub to ship precision medication primarily based remedies,” concluded Professor Patrick Tan, Government Director of PRECISE.
Disclaimer: This text doesn’t essentially mirror the views of AsianScientist or its workers.